Notice Regarding Workforce Reduction and Other Rationalization Measures at U.S. Consolidated Subsidiary
Filed with TSE · · 2 pages · English
Summary by 6ix AI
Japan Medical Dynamic Marketing, Inc. has announced workforce reductions and other rationalization measures at its U.S. subsidiary, Ortho Development Corporation, due to changes in the business environment and declining sales. The company aims to improve profitability by aligning ODEV's organizational structure with its business scale while maintaining essential functions for business continuity. The company anticipates recording retirement-related expenses and other costs in the upcoming fiscal year as a result of these measures.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Japan Medical Dynamic Marketing, Inc. on 6ix
Earlier from Japan Medical Dynamic Marketing
- Consolidated Financial Results for the Three Months Ended June 30, 2026(Under Japanese GAAP)_
- Matters Concerning Controlling Shareholders, etc.
- Plan to Comply with the Listing Maintenance Criteria (Market Capitalization of Tradable Shares), Including the Initiation of an Improvement
- 〔Delayed〕Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2023
Later from Japan Medical Dynamic Marketing
- Consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP)
- Notice Concerning Differences Between Forecast and Actual Consolidated Financial Results for the Second Quarter of the FYE Mar
- Notice Regarding the Clarification of Management Responsibility and the Promotion of a Business Improvement Plan
Follow Japan Medical Dynamic Marketing into a list and get an email when it puts out news.
Follow Japan Medical Dynamic Marketing